SCHEMBL4758571

SCHEMBL4758571

COc1cc2c(cc1OC)N(C)c1ccccc1S2

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.63
NOX1 Q9Y5S8 5/20 0.57
MEN1 O00255 3/20 0.57
KMT2A Q03164 3/20 0.57
L3MBTL1 Q9Y468 2/20 0.57
ADRA2A P08913 1/20 0.57
ADRA2B P18089 1/20 0.57
ADRA2C P18825 1/20 0.57
CHRM3 P20309 1/20 0.57
SLC6A2 P23975 1/20 0.57
HTR2C P28335 1/20 0.57
SLC6A4 P31645 1/20 0.57
DRD3 P35462 1/20 0.57
HTR2B P41595 1/20 0.57
MAPT P10636 3/20 0.51
LMNA P02545 2/20 0.51
MAPK1 P28482 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
BCHE P06276 2/20 0.50
ACHE P22303 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31297935 0.84 MAOA (0.51) MAOANOX1MEN1KMT2AL3MBTL1
SCHEMBL7123151 0.80 SNCA (0.69) MAOANOX1MEN1KMT2AL3MBTL1
SCHEMBL31297952 0.80 MAOA (0.63) MAOANOX1MEN1KMT2AL3MBTL1
SCHEMBL7124233 0.80 MAOA (0.63) MAOANOX1MEN1KMT2AL3MBTL1
SCHEMBL231247 0.80 MAOA (1.00) MAOANOX1MEN1KMT2AL3MBTL1
SCHEMBL29377505 0.80 MAOA (1.00) MAOANOX1MEN1KMT2AL3MBTL1
SCHEMBL7170967 0.79 MAOA (0.73) MAOANOX1MEN1KMT2AL3MBTL1
SCHEMBL10500827 0.78 MAOA (0.51) MAOANOX1MEN1KMT2AL3MBTL1
SCHEMBL12190943 0.77 BCHE (0.50) MAOANOX1MEN1KMT2AMAPT
SCHEMBL12793430 0.77 MAOA (0.70) MAOANOX1MEN1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1765797-A4 PHENOTHIAZINE DERIVATIVES AND THEIR METHOD OF USE UNIV KANSAS CT FOR RES INC (US) 2008-02-06 EP disclosed
EP-1765797-A1 PHENOTHIAZINE DERIVATIVES AND THEIR METHOD OF USE University of Kansas Center for Research, Inc. (US) 2007-03-28 EP disclosed
WO-2006002441-A1 PHENOTHIAZINE DERIVATIVES AND THEIR METHOD OF USE UNIVERSITY OF KANSAS (US) 2006-01-05 WO disclosed
US-20050288279-A1 Phenothiazine derivatives and their method of use KANSAS MEDICAL CENTER, UNIVERSITY OF 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288279-A1 Phenothiazine derivatives and their method of use SHBG, GPR119, BRDT MAOA 1651/4885NOX1 3177/4885MEN1 2558/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.